Emyria LtdASX: EMD

Emyria Engages Calvert Labs for Preclinical CBD studies

· Issued by Emyria Ltd

Filed with ASX · · 3 pages · English

● Emyria has signed a Master Services Agreement (MSA) with leading North American preclinical contract research organisation (CRO), Calvert Labs, an Altasciences Company in support of Emyria’s TGA and FDA registration programs ● Calvert Labs, an Altasciences Company, has a proven track record of performing FDA-approved studies across a broad range of therapeutic indications and specialises in the

Emyria Ltd on 6ix

Earlier from Emyria

Later from Emyria

All Emyria news releases